TELA Bio, Inc. (NASDAQ: TELA) has announced the European launch of its OviTex Inguinal Reinforced Tissue Matrix, the first ...

Europe has long had a biotechnology strategy. Over time, that work led to the Strategy on Bioeconomy, which the European ...

OviTex® Inguinal, the only reinforced tissue matrix created especially for laparoscopic and robotically assisted inguinal ...

As part of BIO-Europe Spring Digital, pharmaphorum founder Dr. Paul Tunnah moderated a panel discussion about big data, AI and applications in the real world. The expert panel explored the ...

Morningstar brands and products Company Portfolio ...

“We anticipate a highly productive meeting at BIO-Europe Spring as we continue to garner interest in our strategic approach to developing neuroplastogenic molecules, led by EB-003, for the ...

Michelin will invest over $60 million to construct a demonstration plant for a bio-sourced, non-toxic molecule—a molecule ...

Based on market research, inguinal hernia repair is the most common type of hernia repair. MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commerc ...

The world’s first carbon-negative ocean calcium sand-containing compostable tray was recognized in international ...

Bluebird bio’s departure from Europe signals rough seas ahead for gene therapy developers, who are trying to gain market access for their products. Initially, Bluebird bio set a $1.8 million ...